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Effect of Addition of an Intimate Partner Violence Intervention
to a Nurse Home Visitation Program on Maternal Quality of Life
A Randomized Clinical Trial
Susan M. Jack, RN, PhD; Michael Boyle, PhD; Christine McKee, MA; Marilyn Ford-Gilboe, RN, PhD; C. Nadine Wathen, PhD; Philip Scribano, DO, MSCE;
Danielle Davidov, PhD; Diane McNaughton, RN, PhD; Ruth O’Brien, RN, PhD; Carolyn Johnston, RN, MA; Mariarosa Gasbarro, MA; Masako Tanaka, PhD;
Melissa Kimber, PhD; Jeffrey Coben, MD; David L. Olds, PhD; Harriet L. MacMillan, CM, MD
IMPORTANCE Intimate partner violence (IPV) is a public health problem with significant
adverse consequences for women and children. Past evaluations of a nurse home visitation
program for pregnant women and first-time mothers experiencing social and economic
disadvantage have not consistently shown reductions in IPV.
OBJECTIVE To determine the effect on maternal quality of life of a nurse home visitation program
augmented by an IPV intervention, compared with the nurse home visitation program alone.
DESIGN, SETTING, AND PARTICIPANTS Cluster-based, single-blind, randomized clinical trial at
15 sites in 8 US states (May 2011-May 2015) enrolling 492 socially disadvantaged pregnant
women (16 years) participating in a 2.5-year nurse home visitation program.
INTERVENTIONS In augmented program sites (n = 229 participants across 7 sites), nurses
received intensive IPV education and delivered an IPV intervention that included a clinical
pathway to guide assessment and tailor care focused on safety planning, violence awareness,
self-efficacy, and referral to social supports. The standard program (n = 263 participants
across 8 sites) included limited questions about violence exposure and information for
abused women but no standardized IPV training for nurses.
MAIN OUTCOMES AND MEASURES The primary outcome was quality of life (WHOQOL-BREF;
range, 0-400; higher score indicates better quality of life) obtained through interviews at
baseline and every 6 months until 24 months after delivery. From 17 prespecified secondary
outcomes, 7 secondary end points are reported, including scores on the Composite Abuse
Scale, SPAN (Startle, Physiological Arousal, Anger, and Numbness), Prime-MD Patient Health
Questionnaire, TWEAK (Tolerance/Worry About Drinking/Eye-Opener/Amnesia/C[K]ut Down
on Drinking), Drug Abuse Severity Test, and the 12-Item Short-Form Health Survey (physical
and mental health), version 2.
RESULTS Among 492 participants enrolled (mean age, 20.4 years), 421 (86%) completed the
trial. Quality of life improved from baseline to 24 months in both groups (change in
WHOQOL-BREF scores from 299.5 [SD, 54.4] to 308.2 [SD, 52.6] in the augmented program
group vs from 293.6 [SD, 56.4] to 316.4 [SD, 57.5] in the standard program group). Based on
multilevel growth curve analysis, there was no statistically significant difference between
groups (modeled score difference, −4.9 [95% CI, −16.5 to 6.7]). There were no statistically
significant differences between study groups in any of the secondary participant end points.
There were no adverse events recorded in either group.
CONCLUSIONS AND RELEVANCE Among pregnant women experiencing social and economic
disadvantage and preparing to parent for the first time, augmentation of a nurse home
visitation program with a comprehensive IPV intervention, compared with the home
visitation program alone, did not significantly improve quality of life at 24 months after
delivery. These findings do not support the use of this intervention.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT01372098
JAMA. 2019;321(16):1576-1585. doi:10.1001/jama.2019.3211
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N urse-Family Partnership is an evidence-based pro-gram of prenatal and infancy home visiting providedby nurses to socially and economically disadvan-
taged first-time mothers. In 3 randomized clinical trials
conducted in the United States, this nurse home visitation
program was shown to improve pregnancy outcomes,
child health, and maternal life-course development.1 In the
first trial, a notable finding was a reduction in state-verified
reports of child abuse and neglect at the 15-year follow-up
among the nurse-visited families.2 This reduction was not
shown when mothers reported moderate to severe levels of
intimate partner violence (IPV).
Across trials of this home visitation program in the
United States as well as the Netherlands,3-6 there have been
conflicting findings about program effects on IPV. While the
standard program model included IPV screening questions as
well as educational information for women disclosing IPV,
this was not considered sufficient to meet women’s needs,
nor did nurses perceive that they had sufficient knowledge
or skills to address IPV.7,8 These findings indicated a need
to develop a more comprehensive IPV intervention to aug-
ment the model and core curriculum of this nurse home visi-
tation program.8
The aim of this trial was to compare the effectiveness of a
nurse home visitation program augmented with a multicom-
ponent IPV intervention compared with delivery of the stan-
dard nurse home visitation program. It was hypothesized
that the augmented program would be more effective than
the standard program in improving maternal quality of life
among this group of women at high risk of IPV.
Methods
Trial Design and Oversight
This cluster-based, single-blind, randomized clinical trial was
conducted from May 2011 to May 2015. A cluster was defined
as a distinct site delivering the nurse home visitation pro-
gram. A cluster randomized clinical trial was used to prevent
contamination. Randomly assigning women within the nurse
home visitation program sites to receive the augmented IPV
intervention would have put nurses who had received the
study-specific IPV training in a compromised position, to ap-
ply their new knowledge/skills or not, which was identified a
priori as an undesirable condition for this study. The trial pro-
tocol is available in Supplement 1.
This study was conducted with approval from the
Hamilton Integrated Research Ethics Board, McMaster Uni-
versity, as well as approvals from organizational and site-
specific institutional review boards. A data and safety moni-
toring committee oversaw the ongoing safety of participants
by monitoring primary outcomes. A systematic, formal pro-
cess was instituted for this committee to review any reports
of adverse events. Written informed consent was obtained
from each study participant (for those aged 16 up to 18 years,
participant assent and consent of a parent or guardian was
required), as well as from each participating nurse, before
enrollment in the study.
Study Setting and Participants
Eligible nurse home visitation program sites had no previous
involvement in the development or pilot testing of the IPV in-
tervention and no ongoing participation in other program-
related research. Within each site, all women 16 years and older
who spoke English and met the nurse home visitation pro-
gram criteria (eg, enrolled before 28 weeks’ gestation, living
in poverty, first live birth) were eligible. Before the fourth
planned home visit, the nurse determined eligibility and ob-
tained written permission to share contact information with
a research assistant, who followed up to secure written in-
formed consent to participate in the trial.
Sample Size and Randomization
Allowing for a trial refusal rate of 15% and losses to
follow-up of 20%, initial funding for this study was suffi-
cient to enlist and retain 90 participants per group (n = 180)
in 10 sites that included 18 participants per site. With α set
at P < .05 (2-tailed), 90 women per group provided 80%
power (1-β) to detect a moderate improvement in the inter-
vention group vs standard nurse home visitation group
(Δ = 20.0 units—a standardized effect, d = 0.459) on the pri-
mary outcome (quality of life, as measured by the World
Health Organization Quality of Life–BREF [WHOQOL-BREF]
instrument).10,11 This estimate allowed for a design effect
of 1.18 derived from [1 + (n − 1) × ρ], in which n = 18 (mean
cluster size) and ρ = 0.01 (the between-cluster differences
[intraclass correlation coefficient]). Additional funding
made it possible to enlist 5 more sites, resulting in 225 par-
ticipants per group in 15 sites that included 32 participants
per site and enabled the study to detect a smaller effect size
(Δ = 13.6 units—a standardized effect d = 0.30). Effect sizes
were estimated12 by (Z(1 − α/2) + Z1-β)2 2σ2 [1 + (n − 1) ρ]/Δ2,
where Z(1 − α/2) = 1.96; Z(1 − β) = 0.84; σ2 = 2025 (the original
variance associated with the WHOQOL-BREF); and the
design effect increased to 1.31 based on [1 + (32 − 1) × 0.01].
For randomization, the sites were stratified by the num-
ber of nurses per site, either a small site (1-7 nurses) or a large
site (≥8 nurses). In total, 10 small sites and 7 large sites were
randomized. Within the strata, using a randomization table,
Key Points
Question Does augmentation of a nurse home visitation program
with an intimate partner violence intervention, starting in
pregnancy, compared with the home visitation program alone,
lead to improved maternal quality of life at 24 months
after infant delivery?
Findings In this cluster randomized clinical trial that included
492 pregnant women, randomization to the augmented program
compared with nurse home visitation alone resulted in maternal
quality-of-life scores at 24 months postdelivery of 311.3 vs
316.2 (measured using the WHOQOL-BREF scale; range,
0-400)—a difference that was not statistically significant.
Meaning These findings do not support augmenting a nurse
home visitation program with this complex, multifaceted intimate
partner violence intervention.
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each site was randomly assigned either to the intervention
group or standard nurse home visitation group. Once half of
the sites in each stratum had been allocated to one of the con-
ditions (ie, 5 sites for the small and 4 sites for the larger sites),
remaining sites were assigned to the other condition to en-
sure a balance in the number of sites per group. The random-
ization of all sites occurred in February 2011. Outcome asses-
sors were blinded to group assignment, but it was not possible
to blind program sites or researchers. Across sites, initiation
of participant recruitment occurred at different times be-
cause of local logistical issues.
Intervention
In sites randomized to the intervention group, nurses deliv-
ered the standard nurse home visitation program aug-
mented with an IPV intervention specifically developed to
support nurses to identify women exposed to IPV and then
respond with a tailored clinical response. This intervention8
(see eFigure in Supplement 2 for conceptual model)
included a comprehensive program of nurse IPV education,
guidelines for reflective supervision, a checklist to assist
sites to implement the intervention, and a clinical pathway
to guide decision making that included elements of assess-
ment, diagnosis, care planning, and intervention tailored to
the participant’s needs (component summary listed in the
eTable in Supplement 2). This complex, multicomponent,
tailored intervention consisted of (1) universal assessment
of safety8 or case-finding assessment approaches to identify
IPV exposure and (2) empathic response to IPV disclosure,
followed by (3) risk assessment (administration of the
Danger Assessment instrument13) plus an adapted brief
empowerment intervention14 including immediate discus-
sion of safety options and (4) assessment of mental health,
substance use, and stage of readiness to address safety to
plan a nursing response tailored to a woman’s needs that
focuses on (5) safety, awareness of IPV health effects, self-
efficacy, and system navigation. System navigation involves
identifying, referring, and actively facilitating participant
access to external domestic violence, legal, housing, or
other health or social care services.
In the standard nurse home visitation group, nurses
visited study participants regularly from early in pregnancy
until the child’s second birthday (maximum, 64 home vis-
its). In each visit, nurses addressed content from 6 domains:
personal health, environmental health, life course devel-
opment, maternal role, family and friends, and health
and human services. Nurses did not receive program-
specific IPV training as part of their orientation to the
nurse home visitation program; however, the provision of
professional development on IPV was provided at the dis-
cretion of supervisors at individual sites. The existing
guidelines of the nurse home visitation program required
that a relationship assessment based on a modified Abuse
Assessment Screen15 be conducted by the nurse at 3 points
in time. If a woman enrolled in the program disclosed cur-
rent IPV, program guideline recommendations were to
assess safety, provide information about IPV, and refer
to appropriate services.
Measures
Study participants completed a baseline interview in person
with a research assistant; subsequent interviews were con-
ducted by telephone at 6 months postpartum and then every
6 months until 24 months postpartum. Research data contin-
ued to be collected for participants who dropped out of the
program but remained in the study. As retention strategies,
participants were contacted at 2-month intervals to update
their contact information and compensated with a $25 gift
card for the baseline interview and a $50 gift card for each
subsequent interview.
Baseline demographic data were collected about all par-
ticipants, including age, ethnicity, race, level of education,
marital status, income, employment, presence of partner,
and presence of children aged 0 to 16 years at least part-
time. Ethnicity was included in this study to inform general-
izability, given that many of the sites that participated were
in the southern United States. Participants self-identified in
response to fixed categories for ethnicity and race as out-
lined in Table 1.
Primary Outcome
The primary end point, quality of life, was measured
using the WHOQOL-BREF instrument, a 26-item tool that
includes 4 quality-of-life domains: physical (7 items), psy-
chological (6 items), social (3 items), and environmental
(8 items).10,11 A recent meta-analysis of clinical trials using
the WHOQOL-BREF to assess outcomes identified substantial
between-study variability in sensitivity to change across the
domains.16 Because of this variability and the multidimen-
sional effect on life quality expected of the intervention, the
4 domains, each of which was scored on a standardized scale
(0-100), were combined in this study to represent overall
quality of life (0-400). All items are positively oriented, rated
on a 5-point intensity or frequency continuum, and refer to
the previous 2 weeks. Reliability of internal consistency
(Cronbach α) in this study at baseline was 0.91. Based on
Cohen d, a minimally clinically important and achievable
standardized effect size is about d = 0.30.16
Secondary Outcomes
Data on secondary end points were collected every 6
months. IPV recurrence was measured using the Composite
Abuse Scale.17,18 This 30-item instrument has 4 subscales:
severe combined abuse, emotional abuse, physical abuse,
and harassment (scored as the sum of 30 Likert items
[range, 0 [never] to 5 [daily]; a score of 7 or more was used as
the criterion for IPV exposure). Posttraumatic stress disorder
was assessed using the 4-item SPAN (Startle, Physiological
Arousal, Anger, and Numbness) screen, derived from the
Davidson Trauma Scale (4 items with 5 response options
each, ranging from 0 [“not at all”] to 4 [“extremely distress-
ing”]; a score of ≥5 indicated presence of posttraumatic
stress disorder).19 Depressive symptoms were assessed
using the depression subscale from the PRIME-MD Patient
Health Questionnaire20 (items are summed [range, 0-27],
with a threshold score of ≥10 representing moderate de-
pression; a 5-point change is considered to indicate clinical
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importance). Alcohol misuse was assessed with the 5-item
TWEAK (Tolerance, Worry, Eye-Opener, Amnesia, C(K)ut
Down on Drinking) screening tool (tolerance of ≥3 drinks
scored 2 points; a “yes” response to “worry” scored 2
points; and the remaining items scored 1 point each; a total
score of ≥2 points indicated an alcohol problem).21,22 Two
questions from the Drug Abuse Severity Test assessed
excess use of prescription drugs and use of street drugs23;
endorsing either question indicated a drug problem. The
12-Item Short-Form-12 Health Survey, version 2, a valid and
reliable short form of the widely used 36-Item Short Form
Health Survey, was used to measure global mental and
physical health and well-being.24
Prespecified secondary outcomes not reported here
include Domestic Violence Survivor Assessment,25 the Inti-
mate Partner Violence Strategies Index,26 the Childhood
Experiences of Violence Questionnaire Short Form,27 the
Childhood Trauma Questionnaire,28 a modified version of
the Health and Social Service Utilization questionnaire,29
child health outcomes (eg, birth weight, length of gestation,
injuries, emergency department visits, hospitalizations,
immunizations, developmental delays), child protective ser-
vices reports, adherence to the standard nurse home visita-
tion program components (multiple program indicators as
measured by the nurse home visitation program clinical
implementation system, such as sociodemographic factors,
maternal health behaviors, psychosocial characteristics,
infant neonatal intensive care unit and hospital visits, pat-
terns of welfare use), nurse performance, and additional
sources assessing IPV.
Post hoc End Points
Nurses at intervention sites completed an intervention imple-
mentation log to document whether a procedure on the clini-
cal pathway was completed (yes/no) and the date.
A mixed-methods evaluation of the education compo-
nent of the intervention was conducted to measure changes
in nurse knowledge and confidence (Public Health Nurses’
Responses to Women Who are Abused Scale).30 Additionally,
a qualitative process evaluation to identify factors influenc-
ing implementation and uptake of the intervention was con-
ducted that included focus groups with nurses (n = 46) at
each of the 7 intervention sites at the end of the trial. Find-
ings from these latter 2 post hoc end points are not reported
in this article.
Data Analysis
Multilevel Models for Windows (MLwiN; Centre for Multi-
level Modelling) version 2.1031 was used to model growth
trajectories for quality of life (linear model) and IPV recur-
rence (logistic model). The growth curve analysis included
2 steps: first, repeat assessments for each participant were
modeled as a function of time (number of months, in
6-month intervals since baseline) to estimate individual tra-
jectories that include a starting point (baseline) and change
per unit of time or growth (trajectory) for each person; and
second, between-group differences were estimated at base-
line and for rates of change.
To account for the study design, with its potential
effects of clustering, site was included as a separate level in
the analysis and time was allowed to vary between sites or
respondents (specified as random effects) if there was
empirical evidence of between-site or between-participant
variation in response trajectories. Plotting trajectories of
response showed some curvature (ie, an acceleration or
deceleration of response with time). Accordingly, response
was modeled in relation to a polynomial function of time
that could include linear, quadratic (time squared) and cubic
(time cubed) terms to improve model fit. Baseline assess-
ments were included in the growth models. Baseline differ-
ences were treated as random and not adjusted for in the
analyses. The intent-to-treat principle was followed as
closely as possible, allowing for dropouts and losses to
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No. of all nurse home visitors
(median No. per study site)
77 (4) 101 (7)
Study Participants, No./No. (%)a
All participants 229 263
Age, mean (SD), y 20.3 (3.6) 20.5 (3.7)
Ethnicity: Hispanic/Latina
background
121/196 (61.7) 106/252 (42.1)
Race
White only 135/197 (68.5) 143/251 (57.0)
Black or African American only 32/197 (16.2) 71/251 (28.3)
Asian only 0/197 (0) 3/251 (1.2)
American Indian or Alaska
Native only
3/197 (1.5) 3/251 (1.2)
Native Hawaiian or other
Pacific Islander only
0/197 (0) 1/251 (0.4)
Multirace categories 10/197 (5.1) 16/251 (6.4)
Declined to self-identify 17/197 (8.6) 14/251 (5.6)
Graduated from high school or
obtained vocational certificate
121/221 (54.8) 135/259 (52.1)
Single or never married 178/229 (77.7) 216/262 (82.4)
Dependent or no income 82/221 (37.1) 87/252 (34.5)
Employed or self-employedb 45/222 (20.3) 62/246 (25.2)
Main source of income was wages
or salary
46/220 (20.9) 59/250 (23.6)
No current partner 23/229 (10.0) 36/261 (13.8)
Children (0-16 y) living at home
at least part time
78/225 (34.7) 114/262 (43.5)
Abbreviation: IPV, intimate partner violence.
a No. of participants with a “yes” response on binary measures/No. of
participants with a response.
b Response to question, “What is your MAIN activity? (Please choose only one).”
Response choices were employed or self-employed; helping with family
business or farm; unemployed; student, in school, in training; retired; ill or
disabled for a long time or permanently; maternity leave; looking after the
home and/or family; other.
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follow-up; sites and participants within these categories
were analyzed as randomized. Growth curve models use
all available assessments, so participants contributing
assessments on any occasion were included in the analysis.
The effect on the primary outcome of between-group,
baseline differences in the sociodemographic character-
istics of participants exceeding |15%| was investigated post
hoc by statistically adjusting for them in separate growth
models. Results are presented at 24 months as score dif-
ferences with 95% CIs in multilevel linear growth models
and as percentage differences and 95% CIs in logistic
growth models.
Statistical significance was set at P < .05 (2-sided). Be-
cause of the potential for type 1 error due to multiple compari-
sons, findings for analyses of secondary end points should be
interpreted as exploratory.
Results
Seventeen sites initially expressed interest in participating
in this trial, but after randomization 2 sites subsequently
declined to participate because of workload concerns asso-
ciated with trial involvement. A total of 15 sites delivering
the nurse home visitation program across 8 US states were
enrolled; Table 1 reports information about site locations.
Home visitation nurses in the intervention (n = 77) and
standard nurse home visitation (n = 101) groups were regis-
tered nurses employed to deliver this specific home visita-
tion program. The mean cluster size (mean number of par-
ticipants enrolled across sites) was 32.7 for sites allocated
to receive the intervention and 32.9 for sites allocated to
receive the standard nurse home visitation program. The
median number of home visitation nurses per study site
was 4 in the intervention group and 7 in the standard nurse
home visitation group. The median number of nurse super-
visors in both groups was 1. Figure 1 illustrates the site flow
for the trial.
Recruitment of participants in each site occurred
between May 2011 and September 2012. At the 15 study sites,
1376 of 1789 participants (77%) met the inclusion criteria, and
nurses asked 1082 of 1376 (79%) for permission to share con-
tact information. Among the 1082 asked, 781 (72%) gave per-
mission and 577 of 740 (78%) were contacted by a research
assistant. Of the 577 contacted, 509 (88%) agreed to partici-
pate and 492 of 509 (97%) consented and completed a base-
line interview. A total of 492 participants were followed up
for a minimum of 24 months postpartum between May 2011
and May 2015. Figure 2 and Figure 3 illustrate the flow of par-
ticipants through the phases of the trial.
At baseline, 229 participants were enrolled in the sites
randomized to receive the intervention and 263 participants
were enrolled in the sites that delivered the standard nurse
home visitation program. Thirty-two of 229 participants
(14.0%) in the intervention group and 39 of 263 (14.8%) in
the standard nurse home visitation group missed the last
assessment (24 months) but contributed assessments on
some other occasions.
Table 1 presents participants’ characteristics. The mean
age of participants was 20.3 years (SD, 3.7); 50.7% were
Hispanic/Latina, 62.8% were white, 23.3% were black or
African American, 0.7% Asian, 1.4% American Indian or
Alaskan Native, 0.2% Native Hawaiian or other Pacific
Islander, and 5.9% multiracial; 53.3% had graduated from
high school or obtained a vocational certificate; 80% were
single, and 35.7% were dependents or had no income. There
was between-group balance on the characteristics of partici-
pants related to age, education, marital status, income,
employment, presence of partner, and presence of children
aged 0 to 16 years living at home at least part-time. How-
ever, proportionately more women of Hispanic/Latina back-
ground were allocated to the intervention group than to the
standard nurse home visitation group (61.7% vs 42.1%). For
race, proportionately more white women (68.5% vs 57.0%)
and fewer black or African American women (16.2% vs
28.3%) were allocated to the intervention group than to the
standard nurse home visitation group.
Primary Outcome
In both groups, there were improvements in quality of life.
There were no statistically significant modeled score differ-
ences: women in the intervention group had low quality-of-
life levels at 24 months compared with women in the stan-
dard nurse home visitation group (311.3 vs 316.2; modeled score
difference, −4.9 [95% CI, −16.5 to 6.7]).
Secondary Outcomes
In both groups, there were improvements in all of the sec-
ondary outcomes (IPV, posttraumatic stress disorder,
depression, use of alcohol and other drugs, physical health,
Figure 1. Enrollment, Randomization, and Follow-up
of Sites Flow Diagram
17 Nurse home visitation program
sites assessed for eligibility
0 Excluded
17 Sites randomized
7 Sites (229 participants) included
in analysisa
8 Sites randomized to NFP standard
care + IPV intervention
7 Sites (229 participants) received
intervention as randomizeda
1 Site did not receive intervention
as randomized (workload concerns
associated with trial involvement)
0 Sites lost to follow-up
0 Sites discontinued intervention
8 Sites (263 participants) included
in analysisb
9 Sites randomized to NFP
standard care
8 Sites (263 participants) received
intervention as randomizedb
1 Site did not receive intervention
as randomized (workload concerns
associated with trial involvement)
0 Sites lost to follow-up
0 Sites discontinued intervention
IPV indicates intimate partner violence; NFP, Nurse-Family Partnership.
a Numbers of participants at each site were 45, 19, 43, 38, 10, 36, and 38.
b Numbers of participants at each site were 45, 35, 13, 17, 33, 45, 30, and 45.
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and mental health). However, there were no statistically sig-
nificant modeled score differences between the 2 groups on
any of the 7 reported secondary outcomes. Table 2 shows
the observed group mean values and percent at each mea-
surement occasion for the primary and reported secondary
outcomes. Table 3 shows between-group differences at 24
months based on the multilevel growth models.
Post hoc Outcomes
When between-group baseline differences in ethnic back-
ground (Hispanic/Latina vs other) are adjusted for statisti-
cally in the growth model, there was no significant difference
in quality-of-life score at 24 months between the study
groups (−7.5 [95% CI, −20.4 to 5.4]). There were no statisti-
cally significant between-group modeled score differences at
Figure 2. Participant Flow
1789 Potential participants enrolled in NFP program at study sites
413 Excluded
216 Age
140 Did not speak English
57 Unknown (site level—eg, incomplete eligibility forms)
17 Excluded (did not provide consent)
11 Unable to schedule appointment before fourth nurse visit
4 Discovered to be ineligible at time of consent
2 Unable to schedule appointment before recruitment ended
301 Excluded (refused to be contacted by research assistant)
294 Excluded (not asked for permission to contact)
179 Insufficient time before fourth visit
53 Unknown (site level)
14 Client withdrew
13 Recruitment ended
12 Nurse forgot to ask
10 Client transferred or moved
5 Client rarely seen by nurse
3 Incarcerated
3 Nurse lacked information about study
1 Form not received from nurse
1 Mental illness
163 Excluded (not contacted by research assistant)
83 Unable to contact
41 Past fourth visit when permission to contact received
29 Insufficient time before fourth visit
4 Client moved
4 Site reached enrollment capacity
1 Miscarriage
1 No contact information from nurse
492 Randomized
1376 Eligible for study
1082 Asked for permission to contact
41 Excluded (form not received by research assistant)
68 Excluded (declined to participate)
740 Form received by research assistant
577 Contacted by research assistant
509 Agreed to participate




Effect of an Intimate Partner Violence Intervention on Maternal Quality of Life Original Investigation Research
jama.com (Reprinted) JAMA April 23/30, 2019 Volume 321, Number 16 1581
© 2019 American Medical Association. All rights reserved.
Downloaded From: https://jamanetwork.com/ on 04/01/2021
24 months based on the growth models for any of the sec-
ondary outcomes (Table 3).
Of the 229 participants in the 7 intervention sites, 216
returned implementation logs. Prenatally, the universal
assessment of safety was completed with 154 of 216 partici-
pants (71%). Of the 100 participants who disclosed IPV to the
nurse, only 26 (26%) completed the required Danger Assess-
ment instrument.13 In addition, only 40 of 100 abused
women (40%) received at least 1 component of the tailored
intervention focused on safety, IPV awareness, self-efficacy,
or system navigation.
Discussion
In this trial, augmenting a nurse home visitation program with
a complex, multicomponent IPV intervention did not lead to
additional benefits in the primary outcome or any of the sec-
ondary outcomes.
There are several possible reasons why the augmented
program was not more effective than the standard program.
It is possible that the standard program, given its potency,
improved outcomes such as quality of life and IPV to such an
extent that the augmented practice model did not provide
any incremental benefits to participants. Similar outcomes
observed in both groups may be related to receiving care
from nurses experienced in working with abused women and
providing IPV support through the establishment of a thera-
peutic relationship and addressing maternal needs related to
housing, poverty, mental illness, and social support—issues
that when addressed may also serve to improve the quality of
life for all abused women. This possibility is supported by the
results of a Dutch trial, which showed that use of the stan-
dard nurse home visitation program6 led to a significant
reduction in IPV among nurse-visited mothers compared
with a control group, and by results of a systematic review,
which included the standard nurse home visitation program
evaluated in this trial.32
At the time of this trial there was little evidence for
interventions to address IPV in home visiting. Recent find-
ings suggest that a brief brochure-based intervention focused
on safety planning and empowerment in either nurse or
Figure 3. Participant Flow (Continued)
492 Randomized
229 Randomized to receive NFP standard care + IPV intervention
229 Completed baseline interview and received standard
care + IPV intervention as randomized
263 Randomized to receive NFP standard care
263 Completed baseline interview and received
standard care as randomized
229 Included in primary analysis 263 Included in primary analysis
197 Completed 24-mo interview
32 Did not complete 24-mo interview
1 Participant contacted but did not complete interview
23 Participant could not be contacted for interview
8 Withdrawn (cumulative)
224 Completed 24-mo interview
39 Did not complete 24-mo interview
34 Participant could not be contacted for interview
5 Withdrawn (cumulative)
180 Completed 3-mo interview
49 Did not complete 3-mo interview
25 Participant contacted but did not complete interview
19 Participant could not be contacted for interview
5 Withdrawn (cumulative)
218 Completed 3-mo interview
45 Did not complete 3-mo interview
25 Participant contacted but did not complete interview
17 Participant could not be contacted for interview
3 Withdrawn (cumulative)
192 Completed 6-mo interview
 37 Did not complete 6-mo interview
8 Participant contacted but did not complete interview
23 Participant could not be contacted for interview
6 Withdrawn (cumulative)
226 Completed 6-mo interview
 37 Did not complete 6-mo interview
10 Participant contacted but did not complete interview
23 Participant could not be contacted for interview
4 Withdrawn (cumulative)
184 Completed 12-mo interview
45 Did not complete 12-mo interview
7 Participant contacted but did not complete interview
31 Participant could not be contacted for interview
7 Withdrawn (cumulative)
225 Completed 12-mo interview
38 Did not complete 12-mo interview
9 Participant contacted but did not complete interview
24 Participant could not be contacted for interview
5 Withdrawn (cumulative)
181 Completed 18-mo interview
48 Did not complete 18-mo interview
4 Participant contacted but did not complete interview
37 Participant could not be contacted for interview
7 Withdrawn (cumulative)
219 Completed 18-mo interview
44 Did not complete 18-mo interview
7 Participant contacted but did not complete interview
32 Participant could not be contacted for interview
5 Withdrawn (cumulative)
Continued From Figure 2
IPV indicates intimate partner violence; NFP, Nurse-Family Partnership.
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paraprofessional home visiting programs may be of benefit
to women who disclose IPV at baseline.33 In comparison,
this study evaluated a complex intervention developed for
nurses delivering a model of nurse home visitation that
emphasized discussions of safe relationships and multiple
strategies for IPV assessment with all enrolled women,
Table 2. Observed Outcomes for the Intervention vs Standard Nurse Home Visitation Groups












All participants, No. 229 263 192 225 183 223 181 219 197 224
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Abbreviations: CAS, Composite Abuse Scale; DAST, Drug Abuse Severity Test;
IPV, intimate partner violence; PHD-9, Patient Health Questionnaire 9;
PTSD, posttraumatic stress disorder; SF-12, 12-Item Short-Form Health
Survey; SPAN, Startle, Physiological Arousal, Anger, and Numbness;
TWEAK, Tolerance/WorryAbout Drinking/Eye-Opener/Amnesia/C[K]ut down
on drinking; WHOQOL-BREF, World Health Organization Quality of Life–BREF.
a Assessment occasions for each participant, rather than actual timing
of assessment.
b Range, 0-400; higher score indicates better quality of life. A score of 300 is
a value similar in magnitude to the average score observed in the general
population of young women based on combined individual domain scores.
c No. of participants with a “yes” response on binary measures/No. of
participants with a response.
d Range, 0-150; 7 or higher considered “yes” for presence of IPV.
e Range, 0-16; 5 or higher considered “yes” for presence of PTSD.
f Range, 0-27; 10 or higher considered “yes” for presence of moderate
depression.
g Range, 0-7; 2 or higher considered “yes” for presence of alcohol problem;
assessed at 12-month intervals.
h Range, 0-2; 1 or higher considered “yes” for presence of drug problem;
assessed at 12-month intervals.
i Range, 0-100; scales positively scored. Scores were computed by multiplying
each indicator variable by its respective regression weight (physical or mental
health), and aggregated score was transformed with mean of 50 and SD of 10
in the general US population.
Table 3. Outcome Differences Between Intervention vs Standard Nurse Home Visitation Groups at 24 Months,






Δ (95% CI)a Wald χ2 P Value
Primary Outcomeb
WHOQOL-BREF, mean 311.3 316.2 −4.9 (−16.5 to 6.7) 0.69 .41
Secondary Outcomesb
IPV (CAS), % 13.3 8.9 4.3 (−0.5 to 11.3) 3.01 .08
PTSD (SPAN), % 13.8 14.8 −1.0 (−6.7 to 6.2) 0.08 .78
Depression (PHQ-9), % 10.5 11.5 −1.0 (−5.0 to 5.0) 0.15 .70
Alcohol problem
(TWEAK), %
14.5 11.8 2.7 (−2.3 to 9.7) 0.92 .34
Drug problem
(DAST), %
8.7 5.5 3.2 (−1.4 to 12.1) 1.46 .23
Mental health
(SF-12), mean
49.9 51.0 −1.0 (−2.9 to 0.9) 1.07 .30
Physical health
(SF-12), mean
52.2 52.5 −0.3 (−1.5 to 0.9) 0.27 .60
Abbreviations: CAS, Composite
Abuse Scale; DAST, Drug Abuse
Severity Test; IPV, intimate partner
violence; PHD-9, Patient
Health Questionnaire 9;
PTSD, posttraumatic stress disorder;
SF-12, 12-Item Short-Form Health
Survey; SPAN, Startle, Physiological
Arousal, Anger, and Numbness;
TWEAK, Tolerance/Worry About
Drinking/Eye-Opener/Amnesia/
C[K]ut Down on Drinking;
WHOQOL-BREF, World Health
Organization Quality of Life–BREF.
a Modeled between-group score
difference with no control variables.
b See Table 2 footnotes for scale
definitions for primary and
secondary outcomes.
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followed by immediate risk assessments for participants
experiencing abuse and then long-term tailored intervention
for abused women, including support through the process of
disengaging from the abusive relationship.
A potential limitation of cluster trials with a limited num-
ber of clusters is group imbalance attributable to between-
site differences in the baseline characteristics of participants.
In this study, there was a potentially important difference at
baseline: proportionally more Hispanic/Latina women were
allocated to and retained in the intervention group than the
standard nurse home visitation group. Although controlling
for Hispanic/Latina background increased the group differ-
ences in quality of life at 24 months, these differences were
not statistically significant. While site differences in ability to
retain participants can be a challenge for cluster trials, the
proportion of women retained across sites was relatively high
and showed no between-group differences.
Limitations
This study had several limitations. First, it was not possible
to make previous IPV exposure an eligibility criterion; since
the study intervention was applied to the overall program at
a site level, all women eligible for the nurse home visitation
program at each site were asked to participate in the trial.
Although 19.1% of those entering the trial reported exposure
to IPV, this meant that the opportunity for nurses to focus on
assisting women exposed to IPV was limited to less than one-
fifth of the overall sample. Second, only 36% of women
deemed eligible for the study enrolled in the trial. The study
participants may have had more stable living and health con-
ditions compared with those who were eligible but not
enrolled, and this may have limited the ability to assess
potential intervention effects. Third, post hoc analysis indi-
cated that there were limitations in the implementation of
the intervention; among women who disclosed IPV to their
nurse, a minority (26%) completed a core risk assessment
and less than half received 1 or more tailored intervention
components. The low level of fidelity to the intervention may
have been related to the complexity of the intervention or
issues such as challenges working in the home environment
or insufficient supervisory support with implementation.
Conclusions
Among pregnant women experiencing social and economic
disadvantage and preparing to parent for the first time, aug-
mentation of a nurse home visitation program with an IPV
intervention, compared with the home visitation program
alone, did not significantly improve quality of life at 24
months after delivery. These findings do not support the
use of this intervention.
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